Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BBOT compared with ANL: revenue, margins and what each company keeps, and the suppliers and customers both name
BBOT
BridgeBio Oncology Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
ANL
Adlai Nortye Ltd.
Change
Mkt cap
Revenue
Revenue
vs
Compare
BBOT
BridgeBio Oncology Therapeutics, Inc.
vs
ANL
Adlai Nortye Ltd.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
BBOT
BridgeBio Oncology Therapeutics, Inc.
Change
2.33
▲
+0.68%
· post 2.25
· delayed
Mkt cap
$184.9M
ANL
Adlai Nortye Ltd.
Change
9.52
▲
+1.63%
· post 9.52
· delayed
After hours
Nov 3 '26
delayed
Mkt cap
$898.8M
vs
Compare
After hours
Nov 3 '26
delayed
BBOT
BridgeBio Oncology Therapeutics, Inc.
vs
ANL
Adlai Nortye Ltd.
2.33
▲
+0.68%
post 2.25
delayed
Price
9.52
▲
+1.63%
post 9.52
delayed
$184.9M
Mkt cap
$898.8M
Change
Change
BBOT
2.33
▲
+0.68%
vs
ANL
9.52
▲
+1.63%
After hours
Nov 3 '26
delayed
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
BBOT: latest quarter not drawable. ANL: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only BBOT
2
LDOS
Leidos Biomedical Research
supplier
—
Lawrence Livermore National Security, LLC (LLNS)
unlisted
supplier
Shared
0
No disclosed counterparties: ANL.
Only ANL
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
BBOT, solid
ANL, dashed